Profile | GDS4284 / 223098_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1675.66 | 81 |
GSM687648 | Patient 402 control | 1504 | 80 |
GSM687653 | Patient 403 control | 1282.29 | 78 |
GSM687658 | Patient 404 control | 1428.41 | 79 |
GSM687663 | Patient 411 control | 1817.82 | 83 |
GSM687668 | Patient 422 control | 2283.46 | 85 |
GSM687673 | Patient 424 control | 1754.68 | 82 |
GSM687678 | Patient 425 control | 1726.1 | 81 |
GSM687683 | Patient 427 control | 1463.38 | 79 |
GSM687688 | Patient 428 control | 1105.9 | 76 |
GSM687695 | Patient 441 control | 694.744 | 68 |
GSM687699 | Patient 443 control | 1566.99 | 81 |
GSM687704 | Patient 444 control | 1105.77 | 75 |
GSM687707 | Patient 448 control | 2416.89 | 87 |
GSM687712 | Patient 449 control | 1812.28 | 83 |
GSM687719 | Patient 450 control | 1208.88 | 77 |
GSM687724 | Patient 451 control | 2109.19 | 85 |
GSM687728 | Patient 452 control | 1234.83 | 78 |
GSM687646 | Patient 401 treated 24h | 2216.53 | 85 |
GSM687649 | Patient 402 treated 24h | 1492.89 | 80 |
GSM687665 | Patient 411 treated 24h | 1443.21 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 2033.48 | 84 |
GSM687667 | Patient 411 treated 4 weeks | 2462.47 | 86 |
GSM687670 | Patient 422 treated 24h | 2552.24 | 87 |
GSM687671 | Patient 422 treated 4 weeks | 3332.27 | 90 |
GSM687654 | Patient 403 treated 24h | 1636.72 | 81 |
GSM687675 | Patient 424 treated 24h | 1804.75 | 83 |
GSM687685 | Patient 427 treated 24h | 1348.54 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 1847.32 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 1448.51 | 79 |
GSM687687 | Patient 427 treated 4 weeks | 2187.4 | 85 |
GSM687692 | Patient 428 treated 4h | 1213.07 | 77 |
GSM687716 | Patient 449 treated 4h | 1648.6 | 81 |
GSM687722 | Patient 450 treated 4h | 759.951 | 69 |
GSM687680 | Patient 425 treated 24h | 1231.08 | 77 |
GSM687690 | Patient 428 treated 24h | 921.888 | 73 |
GSM687700 | Patient 443 treated 24h | 1199.24 | 76 |
GSM687705 | Patient 444 treated 24h | 1343.8 | 78 |
GSM687714 | Patient 449 treated 24h | 2087.6 | 84 |
GSM687721 | Patient 450 treated 24h | 1147.52 | 76 |
GSM687682 | Patient 425 treated 4 weeks | 893.886 | 72 |
GSM687694 | Patient 428 treated 4 weeks | 1502.34 | 80 |
GSM687702 | Patient 443 treated 4 weeks | 1337.7 | 78 |
GSM687718 | Patient 449 treated 4 weeks | 1228.59 | 77 |
GSM687723 | Patient 450 treated 4 weeks | 1261.01 | 77 |
GSM687661 | Patient 404 treated 4h | 1230.13 | 77 |
GSM687710 | Patient 448 treated 4h | 2889.45 | 88 |
GSM687726 | Patient 451 treated 4h | 2575.22 | 87 |
GSM687730 | Patient 452 treated 4h | 450.409 | 52 |
GSM687660 | Patient 404 treated 24h | 574.48 | 67 |
GSM687697 | Patient 441 treated 24h | 1045.36 | 75 |
GSM687709 | Patient 448 treated 24h | 2673.95 | 88 |
GSM687725 | Patient 451 treated 24h | 2522.88 | 87 |
GSM687729 | Patient 452 treated 24h | 749.157 | 71 |
GSM687727 | Patient 451 treated 4 weeks | 2555.62 | 87 |
GSM687731 | Patient 452 treated 4 weeks | 1402.05 | 79 |